(a)
The following words and terms, when used in this section, shall have the
following meanings, unless the context clearly indicates otherwise.
"Direct supervision" shall have the same meaning as
"immediate supervision" as set forth at
N.J.S.A.
45:14-41.
"Supervising pharmacist" means a licensed pharmacist
authorized to administer vaccines and related emergency medications pursuant to
the requirements of this section, and who is responsible for the direct
supervision of a registered pharmacy intern or pharmacy extern administering
immunizations to patients pursuant to this section.
(b) The provisions of this section set forth
the requirements for licensed pharmacists, registered pharmacy interns, and
pharmacy externs authorized to administer vaccines and related emergency
medications, which shall be limited to diphenhydramine and epinephrine, to
eligible patients who are 18 years of age and older, consistent with the
requirements at
N.J.S.A.
45:14-63, under the following circumstances:
1. Pursuant to a prescription by a New Jersey
authorized prescriber for a vaccine, related emergency medications, and
pharmacist, pharmacy intern, or pharmacy extern administration of the vaccine
that is patient specific;
2. In
immunization programs implemented pursuant to a New Jersey authorized
prescriber's standing order for the vaccine, related emergency medications, and
administration instructions that are not patient specific; and/or
3. In immunization programs sponsored by
government agencies that are not patient specific.
(c) In order to administer vaccines and
related emergency medications pursuant to this section, a licensed pharmacist
and registered pharmacy intern shall be pre-approved by the Board to perform
such functions. In order to obtain such prior Board approval, a pharmacist or
pharmacy intern shall submit documentation to the Board that establishes that
he or she has satisfied the following education and training requirements:
1. Completion of an academic and practical
curriculum that includes instruction in Centers for Disease Control and
Prevention (CDC) guidelines for vaccine administrations, set forth in Chapter
6, Vaccine Administration, of "Epidemiology and Prevention of
Vaccine-Preventable Diseases (The Pink Book: Course Textbook)," updated 13th
edition, 2015. The CDC vaccine administration guidelines are incorporated
herein by reference, as amended and supplemented, and can be found at the CDC
website,
www.cdc.gov,
specifically,
http://www.cdc.gov/vaccines/pubs/pinkbook/vac-admin.html.
The instruction shall be offered by a provider accredited by the Accreditation
Council for Pharmacy Education (ACPE). The curriculum shall include the
following subjects:
i. The Occupational
Exposure to Bloodborne Pathogens standard of the Occupational Health and Safety
Administration (OSHA), set forth at
29 C.F.R. §
1910.1030, and the New Jersey Public
Employees Occupational Safety and Health (PEOSH) Act, set forth at N.J.S.A.
34:6A-25" et seq., incorporated herein by reference;
ii. CDC Guideline for Infection Control in
Health Care Personnel (1998). The CDC Guideline for Infection Control in Health
Care Personnel (1998) are incorporated herein by reference, as amended and
supplemented, and can be found at the CDC website,
www.cdc.gov, specifically,
http://www.cdc.gov/hicpac/pdf/infectcontrol98.pdf;
iii. Basic immunology;
iv. Communicable or vaccine preventable
disease epidemiology;
v. Vaccine
characteristics, contraindications, monitoring, proper storage and proper
handling;
vi. Informed
consent;
vii. Pre- and post-vaccine
assessment and counseling;
viii.
Immunization record management;
ix.
Immunization schedules established pursuant to "General Recommendations on
Immunization" of the CDC Advisory Committee on Immunization Practices (ACIP)
(December 1, 2006), incorporated herein by reference, as amended and
supplemented. The ACIP recommendations can be found at the CDC website,
www.cdc.gov, specifically,
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5515a1.htm;
x. Injection techniques;
xi. Emergency responses to adverse events;
xii. Medical waste disposal;
and
xiii. Reporting adverse
events;
2. Current
certification in the American Heart Association Basic Life Support (BLS)
protocol, the Red Cross Adult Cardiac Pulmonary Resuscitation (CPR) protocol
for health care providers or in a course that complies with guidelines created
by the International Liaison Committee on Resuscitation (ILCOR). The ILCOR
guidelines, 2010 International Consensus on Cardiopulmonary Resuscitation (CPR)
and Emergency Cardiovascular Care (ECC) Science with Treatment Recommendations,
are incorporated herein by reference, as amended and supplemented, and can be
found at the American Heart Association website,
http://americanheart.org/presenter.jhtml?identifier=3022512,
specifically,
http://circ.ahajournals.org/content/122/16_suppl_2/S250;
and
3. For a licensed pharmacist,
at least two hours of continuing education in immunizations, consistent with
the requirements at
N.J.A.C.
13:39-3A.1, in each biennial renewal
period.
(d) In order to
administer vaccines and related emergency medications pursuant to this section,
a pharmacy extern shall satisfy the education and training requirements at (c)1
and 2 above, which shall be confirmed by the supervising pharmacist.
(e) A registered pharmacy intern or pharmacy
extern who administers vaccines and related emergency medications pursuant to
this section shall act under the direct supervision of the supervising
pharmacist.
(f) Documentation which
establishes that a licensed pharmacist, registered pharmacy intern, or pharmacy
extern has satisfied the education and training requirements at (c) above shall
be maintained at the pharmacy practice site. If the immunization program is to
take place somewhere other than the pharmacy practice site, the documentation
shall be maintained in the licensed pharmacist's, registered pharmacy intern's,
or pharmacy extern's, as applicable, possession at the immunization location.
Such documentation shall be made available for inspection by the
Board.
(g) Board approval granted
to a licensed pharmacist and registered pharmacy intern pursuant to this
section shall be renewed on a biennial basis. A pharmacist seeking such renewal
shall submit documentation which establishes that he or she has satisfied the
requirements at (c)2 and 3 above. A registered pharmacy intern seeking such
renewal shall submit documentation that establishes that he or she has
satisfied the requirements at (c)2 above and the number of such renewals shall
be consistent with
N.J.A.C.
13:39-2.7(d).
(h) An authorized prescriber's standing order
shall specify the procedures that shall be followed for the reporting of
adverse events. The licensed pharmacist and supervising pharmacist shall
maintain and adhere to a manual of policies and procedures for dealing with
acute adverse events. The supervising pharmacist shall ensure that a pharmacy
intern and pharmacy extern adheres to the manual of policies and procedures for
dealing with acute adverse events. The policies and procedures manual shall
require, at a minimum, that the pharmacist, pharmacy intern, or pharmacy
extern, as applicable, immediately notify emergency medical personnel and
obtain assistance for the patient when an adverse event requiring the
administration of emergency medications occurs. The policies and procedures
manual shall be reviewed annually by the licensed pharmacist and supervising
pharmacist and such review shall be documented.
(i) Authorized prescribers' standing orders
shall be maintained in either hard copy or electronic form as provided at (p)
below, and shall be available for inspection by the Board at the pharmacy
practice site and, if applicable, at the immunization location.
(j) Before administration of a vaccine, the
licensed pharmacist, registered pharmacy intern, or pharmacy extern, as
applicable, shall:
1. Screen the patient
using CDC established criteria for each specific vaccine to be
administered;
2. Counsel the
patient and/or the patient's representative about contraindications, proper
care of the injection site, and instructions to contact a physician or
emergency care facility in the event of any adverse reaction;
3. Inform the patient and/or the patient's
representative in writing, in specific and readily understood terms, about the
risks and benefits of the vaccine and provide the patient with a vaccine
information sheet published by the CDC; and
4. Obtain a signed informed consent form,
which complies with the requirements at (k) below, from the patient or the
patient's representative, which shall be maintained at the pharmacy practice
site. If the immunization program is to take place somewhere other than the
pharmacy practice site, the signed informed consent forms shall be maintained
in the licensed pharmacist's, registered pharmacy intern's, or pharmacy
extern's, as applicable, possession at the immunization location, and then
transferred to the pharmacy practice site. The signed informed consent forms
shall be maintained in either hard copy or electronic form as provided at (p)
below.
(k) The informed
consent form provided by a licensed pharmacist, registered pharmacy intern, or
pharmacy extern, as applicable, to a patient shall contain a check-off box
which authorizes the pharmacist, pharmacy intern, or pharmacy extern, as
applicable, to send copies of the patient's vaccine documentation to the
patient's primary care provider, and another check-off box which prohibits the
pharmacist, pharmacy intern, or pharmacy extern, as applicable, from sending
copies of the patient's vaccine documentation to the patient's primary care
provider. The informed consent form shall specify that a patient's failure to
select one of the two check-off boxes shall result in the patient's vaccine
documentation being sent to the patient's primary care provider, if
identified.
(l) The licensed
pharmacist, registered pharmacy intern, or pharmacy extern, as applicable,
shall document all immunizations he or she performs and such documentation
shall be maintained at the pharmacy practice site. If the immunization program
is to take place somewhere other than the pharmacy practice site, the
documentation shall be maintained in the licensed pharmacist's, registered
pharmacy intern's, or pharmacy extern's, as applicable, possession at the
immunization location, and then transferred to the pharmacy practice site. Such
documentation shall be retained in either hard copy or electronic form,
consistent with (p) below, and shall be made available for inspection by the
Board. Such documentation shall include:
1.
The patient's name, address, telephone number, date of birth, allergies and
gender;
2. The vaccine
administered, the manufacturer, expiration date, lot number, site of
administration, and dose administered;
3. The date of original order and the date of
administration(s);
4. The name and
address of the authorized prescriber and supervising pharmacist, if applicable,
and the name and address of the licensed pharmacist, registered pharmacy
intern, or pharmacy extern administering the dose, and the immunization
location, if different from the pharmacy practice site; and
5. The name and address of the patient's
primary care provider, if provided.
(m) The licensed pharmacist or, as
applicable, supervising pharmacist for a registered pharmacy intern or pharmacy
extern shall document in detail and immediately report all clinically
significant adverse events to the authorized prescriber, and to the primary
care provider, if identified and if authorized on the informed consent form
consistent with (k) above. The licensed pharmacist or supervising pharmacist,
as applicable, shall, within 72 hours, report such events to the appropriate
government reporting system.
(n)
The licensed pharmacist, registered pharmacy intern, or pharmacy extern, as
applicable, shall provide a copy of all patient related documentation and a
copy of the signed informed consent form to each patient receiving an
immunization, or to the patient's representative, to the patient's primary care
provider, if provided and if authorized on the informed consent form consistent
with (k) above.
(o) The supervising
pharmacist or pharmacist-in-charge shall report an immunization administered to
a patient by a pharmacist, pharmacy intern, or pharmacy extern to the New
Jersey Immunization Information System, established pursuant to
N.J.S.A.
26:4-134, as required pursuant to
N.J.A.C.
8:57-3.16, for inclusion in the patient's
registry.
(p) All documentation and
records required to be maintained by this section shall be maintained in either
hard copy or electronic form for a period of not less than seven years from the
date of most recent entry and shall be supplied to any physician or health care
provider upon receipt of a signed patient release of health information form.
All records shall be made available to persons authorized to inspect them under
State and Federal statutes and regulations. The oldest six years of information
shall be maintained in such a manner so as to be retrievable and readable
within two weeks. The most recent one year of information shall be retrievable
and readable within one business day. Records not currently in use need not be
stored in the pharmacy, but the storage facilities shall be secure. Patient
records shall be kept confidential.
(q) In the case of immunization programs
implemented pursuant to a physician's standing order, a licensed pharmacist
shall be supervised by the delegating physician. Supervision by the delegating
physician shall be deemed adequate if the delegating physician:
1. Is responsible for formulating or
approving a standing order, periodically reviewing the order and the services
provided to patients under the order;
2. Is geographically located to be easily
accessible to the pharmacy practice site and, if applicable, to the
immunization location.
3. Is
available through direct telecommunication for consultation, assistance, and
direction; and
4. Receives annual
status reports on the immunization program as administered by the
pharmacist.